Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eshwar Mahenthiralingam

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Paediatric Respiratory Reviews|May 17, 2014
Emerging cystic fibrosis pathogens and the microbiomeEshwar Mahenthiralingam
Journal of Nematology|March 7, 2009
Strains from the Burkholderia cepacia Complex: Relationship to Opportunistic PathogensPeter Vandamme, Eshwar Mahenthiralingam
Journal of the Royal Society of Medicine|August 9, 2003
Sequencing of the Pseudomonas aeruginosa and Burkholderia cepacia genomes and their applications in relation to cystic fibrosisDeborah A Miller, Eshwar Mahenthiralingam
Cell Surface (Amsterdam, Netherlands)|October 24, 2022
Discovery, mode of action and secretion of <i>Burkholderia</i> sensu lato key antimicrobial specialised metabolitesYoana D Petrova, Eshwar Mahenthiralingam
Frontiers in Microbiology|October 15, 2021
The Hidden Genomic Diversity, Specialized Metabolite Capacity, and Revised Taxonomy of <i>Burkholderia</i> Sensu LatoAlex J Mullins, Eshwar Mahenthiralingam
Journal of Medical Microbiology|July 23, 2002
Burkholderia cepacia complex infection in patients with cystic fibrosisEshwar Mahenthiralingam, Adam Baldwin, Peter Vandamme
Microbiology Resource Announcements|December 12, 2024
Complete genome sequence of the biopesticidal <i>Burkholderia ambifaria</i> strain BCC0191Gordon Webster, Alex J Mullins, Eshwar Mahenthiralingam
Journal of Microbiological Methods|January 9, 2021
Implementation of microbiota analysis in clinical trials for cystic fibrosis lung infection: Experience from the OligoG phase 2b clinical trialsRebecca Weiser, Philip D Rye, Eshwar Mahenthiralingam
FEMS Microbiology Letters|October 25, 2013
The life history of Lactobacillus acidophilus as a probiotic: a tale of revisionary taxonomy, misidentification and commercial successMatthew Bull, Sue Plummer, Julian Marchesi, et al.
Journal of Microbiological Methods|January 30, 2014
Evaluation of five selective media for the detection of Pseudomonas aeruginosa using a strain panel from clinical, environmental and industrial sourcesRebecca Weiser, Denise Donoghue, Andrew Weightman, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Paediatric Respiratory Reviews|May 17, 2014
Emerging cystic fibrosis pathogens and the microbiomeEshwar Mahenthiralingam
Journal of Nematology|March 7, 2009
Strains from the Burkholderia cepacia Complex: Relationship to Opportunistic PathogensPeter Vandamme, Eshwar Mahenthiralingam
Journal of the Royal Society of Medicine|August 9, 2003
Sequencing of the Pseudomonas aeruginosa and Burkholderia cepacia genomes and their applications in relation to cystic fibrosisDeborah A Miller, Eshwar Mahenthiralingam
Cell Surface (Amsterdam, Netherlands)|October 24, 2022
Discovery, mode of action and secretion of <i>Burkholderia</i> sensu lato key antimicrobial specialised metabolitesYoana D Petrova, Eshwar Mahenthiralingam
Frontiers in Microbiology|October 15, 2021
The Hidden Genomic Diversity, Specialized Metabolite Capacity, and Revised Taxonomy of <i>Burkholderia</i> Sensu LatoAlex J Mullins, Eshwar Mahenthiralingam
Journal of Medical Microbiology|July 23, 2002
Burkholderia cepacia complex infection in patients with cystic fibrosisEshwar Mahenthiralingam, Adam Baldwin, Peter Vandamme
Microbiology Resource Announcements|December 12, 2024
Complete genome sequence of the biopesticidal <i>Burkholderia ambifaria</i> strain BCC0191Gordon Webster, Alex J Mullins, Eshwar Mahenthiralingam
Journal of Microbiological Methods|January 9, 2021
Implementation of microbiota analysis in clinical trials for cystic fibrosis lung infection: Experience from the OligoG phase 2b clinical trialsRebecca Weiser, Philip D Rye, Eshwar Mahenthiralingam
FEMS Microbiology Letters|October 25, 2013
The life history of Lactobacillus acidophilus as a probiotic: a tale of revisionary taxonomy, misidentification and commercial successMatthew Bull, Sue Plummer, Julian Marchesi, et al.
Journal of Microbiological Methods|January 30, 2014
Evaluation of five selective media for the detection of Pseudomonas aeruginosa using a strain panel from clinical, environmental and industrial sourcesRebecca Weiser, Denise Donoghue, Andrew Weightman, et al.
Pageof 12